-
-
CAS
Product Name
Molecular Formula
-
-
-
2-Thiophenecarboxylic acid, tetrahydro-3-oxo-5-phenyl-, ethyl ester
C13H14O3S
-
1,2,3,3a,4,8b-hexahydrocyclopenta[b]indole
C11H13N
-
Silane, [(1E)-1-ethyl-1-butenyl]dimethylphenyl-
C14H22Si
-
Silane, (1E)-1-decenyldimethylphenyl-
C18H30Si
-
C20H19N3O2
-
Pyrylium, tetrafluoroborate(1-)
C5H5O·BF4
-
Benzene, 1-nitro-4-(pentylthio)-
C11H15NO2S
-
6-Benzoxazolol, 5-(1,1-dimethylethyl)-2,7-dimethyl-
C13H17NO2
-
Ethanone, 1-[5-(1,1-dimethylethyl)-2,4-dihydroxyphenyl]-, oxime
C12H17NO3
-
Ethanone, 1-[5-(1,1-dimethylethyl)-2,4-dihydroxy-3-methylphenyl]-,oxime
C13H19NO3
-
6-Benzoxazolol, 5-(1,1-dimethylethyl)-2-methyl-
C12H15NO2
-
12,13-dihydroindeno[1,2,3-gh]tetraphene-12,13-diol
C24H16O2
-
3,4-dihydroindeno[1,2,3-gh]tetraphene-3,4-diol
C24H16O2
-
7-Hexadecyl-3,5-dihydroxy-4-methyl-3-phenyl-6-propyl-3H-benzofuran-2-one
C34H50O4
-
Benzene, 1-(chloromethyl)-4-(octadecyloxy)-
C25H43ClO
-
Benzenemethanol, 4-(octadecyloxy)-
C25H44O2
-
Oxazole, 5-(bromomethyl)-2-phenyl-
C10H8BrNO
-
(1E)-N'-tert-butyl-N-(4-methoxyphenyl)-3-(piperidin-1-yl)propanimidamide
C19H31N3O
-
(1E)-N'-tert-butyl-N-(4-nitrophenyl)-3-(piperidin-1-yl)propanimidamide
C18H28N4O2
-
(1E)-N'-tert-butyl-N-(2-chlorophenyl)-3-(piperidin-1-yl)propanimidamide
C18H28ClN3
-
(1E)-N'-tert-butyl-N-(3-chlorophenyl)-3-(morpholin-4-yl)propanimidamide
C17H26ClN3O
-
(1E)-N'-tert-butyl-N-(2-chlorophenyl)-3-(cyclohexylamino)propanimidamide
C19H30ClN3
-
(1E)-N'-tert-butyl-3-(cyclohexylamino)-N-(2,6-dichlorophenyl)propanimidamide
C19H29Cl2N3
-
ethyl 4-{[(1E)-N-tert-butyl-3-(cyclohexylamino)propanimidoyl]amino}benzoate
C22H35N3O2
-
(1E)-N'-tert-butyl-3-(cyclohexylamino)-N-[3-(trifluoromethyl)phenyl]propanimidamide
C20H30F3N3
-
(1E)-N'-tert-butyl-N-(2-chlorophenyl)-3-[(2-chlorophenyl)amino]propanimidamide
C19H23Cl2N3
-
Propanimidamide,N-(4-chlorophenyl)-3-[(4-chlorophenyl)amino]-N'-(1,1-dimethylethyl)-
C19H23Cl2N3
-
1H,4H-1,3a:4,6a-Diethanopentalene, 1,4-dibromotetrahydro-
C12H16Br2
-
Pyrrolidine, 1-[(4-methoxyphenyl)thioxomethyl]-
C12H15NOS
-
Benzene, [[(1E)-3-methyl-1,3-butadienyl]sulfonyl]-
C11H12O2S
-
3,5-Cyclohexadiene-1,2-dione, 4-chloro-3,6-bis(1,1-dimethylethyl)-
C14H19ClO2
-
C11H16O3
-
2-chloro-5-formylbenzenesulphonic acid
C7H5ClO4S
-
bis(4-methyl-2-oxo-chromen-7-yl) phosphono phosphate
C20H16O11P2
-
2-(4-Cyanophenyl)-5-n-propyl-1,3-dioxane
C14H17NO2
-
Carbamic acid, benzoyl-,2,2,2-trifluoro-1-(4-methylphenyl)-1-(trifluoromethyl)ethyl ester
C18H13F6NO3
-
disodium (2-phenylvinyl)phosphonate
C8H7Na2O3P
-
C40H49ClN4O3
-
C16H26O5
-
2-[(4R)-4,7-dimethyl-1,2,3,4,4a,5,6,8a-octahydronaphthalen-1-yl]prop-2-enoic acid
C15H22O2
-
C25H33NO3
-
C17H14O5
-
(3aR,7aS)-3a-(3,4-dimethoxyphenyl)-1-methyl-1,2,3,3a,7,7a-hexahydro-6H-indol-6-one
C17H21NO3
-
C21H26N2O3
-
C6H8N2
-
Benzene, [(1R,2R)-2-ethoxycyclopropyl]-, rel-
C11H14O
-
Benzene, (2-ethoxycyclopropyl)-, trans-
C11H14O
-
Bicyclo[3.3.1]nonane, 9-bicyclo[3.3.1]non-9-ylidene-2-chloro-, endo-
C18H27Cl
-
2H-Pyran, tetrahydro-2-[[(2Z)-3-iodo-2-propenyl]oxy]-
C8H13IO2
-
C12H12N4O3
-
Acetic acid, [(4-methylphenyl)sulfinyl]-, 1,1-dimethylethyl ester, ion(1-),lithium, (R)-
C13H17O3S·Li
-
5,10-dihydro-11H-indolo[3,2-b]quinolin-11-one
C15H10N2O
-
Copper(II) 6,6,7,7,8,8,8-heptafluoro-2,2-dimethyl-3,5-octanedionate
C20H20CuF14O4
-
C5H6N2O2
-
phenyl 2,4-dichloro-5-sulfamoylbenzenesulfonate
C12H9Cl2NO5S2
-
C21H33N3
-
Quinoline, 5-bromo-6-fluoro-2-methyl-
C10H7BrFN
-
5-bromo-6-chloro-2-methylquinoline
C10H7BrClN
-
Zinc(1+), (aluminum)hexa-m-hydroxydi-
AlH6O6Zn2
-
C28H20B2CoF4N4O4
-
Benzoic acid, 4-heptyl-, 4-nitrophenyl ester
C20H23NO4
-
Ethanone, 2-ethoxy-1-(2-ethoxyphenyl)-
C12H16O3
-
3-dimethyl(3-(N-acrylamido)propyl) ammonium propane sulfonate
-
C22H38N2O7
-
Naphthalene, 1,4,5,8-tetrakis(bromomethyl)-
C14H12Br4
-
(2R)-2,3-bis({12-[(2-methylacryloyl)oxy]dodecanoyl}oxy)propyl 2-(trimethylammonio)ethyl phosphate
C40H72NO12P
-
-
C14H18N4O2
-
C34H25Cl2N10Na4O16S5
-
complement C1 from human serum
-
complement C1 esterase inhibitor human
-
complement C2 deficient serum human
-
-
-
-
-
complement factor B from human serum
-
complement factor H from human plasma
-
complement factor I from human plasma
-
8-benzyl-7-{2-[(2-hydroxyethyl)amino]ethyl}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
C18H23N5O3
-
8-benzyl-7-[2-(ethylamino)ethyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
C18H23N5O2
-
7-(2-aminoethyl)-8-benzyl-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
C16H19N5O2
-
Cresol-formaldehyde copolymer 1,2-naphthoquinonediazido-4-sulfonate
(C10H6N2O4S)x·(C7H8O)n·(CH2
-
C8H16NaO8
-
C21H44
-
C19H40
-
C6H16N2
-
C3H6O3·Ag
-
Phosphorimidic triamide, N,N,N',N',N'',N''-hexamethyl-N'''-propyl-
C9H25N4P
-
Phenol, 4-(5-hexyl-2-pyrimidinyl)-, 4-nitrobenzoate (ester)
C23H23N3O4
-
gona-1(10),2,4,6,8,15-hexaen-12-one
C17H14O
-
gona-1(10),2,4,6,8,15-hexaen-12-ol
C17H16O
-
(7R)-7-(dipropylamino)-5,6,7,8-tetrahydronaphthalen-1-ol hydrobromide (1:1)
C16H26BrNO
-
1-Naphthalenol, 7-(dipropylamino)-5,6,7,8-tetrahydro-, (7S)-
C16H25NO
-
C4H5Cl2NO2
-
1-(4-nitrobenzyl)pyrrolidine-2,5-dione
C11H10N2O4
-
N,N-bis(2-ethylhexyl)-1H-benzotriazole-1-methylamine
C23H40N4
-
C28H18N8O14S2
-
1,4-bis[(3-nitrophenyl)sulfonyl]piperazine
C16H16N4O8S2
-
2-[(pentachlorophenyl)dithio]ethanol
C8H5Cl5OS2
-

